| abstract |
An object of the present invention is to provide a simple and safe prophylactic / therapeutic agent for suppressing the symptoms of type I allergy, which has no side effects and does not require pain such as long-term hospital visits. The present invention provides an IgE antibody production inhibitor characterized by using sphingolipid as an active ingredient, and preferably sphingo obtained by extracting sphingolipid from a plant with an organic solvent and / or supercritical carbon dioxide. It is a lipid, and more preferably, the plant is a potato (for example, konjac flying powder). [Selection diagram] None |